glimepiride has been researched along with Hypergonadotropic Hypogonadism in 1 studies
glimepiride: structure given in first source
Excerpt | Relevance | Reference |
---|---|---|
"Men with type 2 diabetes are often characterized by abnormal plasma testosterone levels." | 5.43 | The effect of testosterone on cardiovascular risk factors in men with type 2 diabetes and late-onset hypogonadism treated with metformin or glimepiride. ( Gilowski, W; Krysiak, R; Okopień, B, 2016) |
"Men with type 2 diabetes are often characterized by abnormal plasma testosterone levels." | 1.43 | The effect of testosterone on cardiovascular risk factors in men with type 2 diabetes and late-onset hypogonadism treated with metformin or glimepiride. ( Gilowski, W; Krysiak, R; Okopień, B, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Krysiak, R | 1 |
Gilowski, W | 1 |
Okopień, B | 1 |
1 other study available for glimepiride and Hypergonadotropic Hypogonadism
Article | Year |
---|---|
The effect of testosterone on cardiovascular risk factors in men with type 2 diabetes and late-onset hypogonadism treated with metformin or glimepiride.
Topics: Aged; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; H | 2016 |